학술논문
Exploring red blood cells as a novel tolerogenic approach for Factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II
Document Type
Article
Author
Source
Hämostaseologie; February 2023, Vol. 43 Issue: 1, Number 1 Supplement 1
Subject
Language
ISSN
07209355; 25675761